Dentsply Sirona 2Q 2023 Financial Results & Supplemental Information

Supplemental financial information for Q2 2023 showing third-party net sales of $224.9M across dental and spine segments, with adjusted EBITDA of $29.7M and an adjusted EBITDA margin of 13.2%. The presentation includes non-GAAP reconciliations and forward-looking statements regarding product development, regulatory challenges, and market conditions.